Clinical Trial Update: A Study to Observe the Effectiveness of Empagliflozin, Other SGLT-2 Inhibitors, or DPP-4 Inhibitors in Patients With Type 2 Diabetes

View source ↗

Summary

A completed clinical trial update reports results from a study evaluating the effectiveness of empagliflozin, other SGLT-2 inhibitors, and DPP-4 inhibitors in a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitors (class)
• Empagliflozin (empagliflozin)
• SGLT-2 inhibitors (class)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED | Results posted: 2024-09-23